UBS spotlights blistering Senate momentum on a sweeping economic bill packed with permanent tax incentives and trade reprieves, all under crushing pressure to meet July deadlines. UBS Sees Fast-Track Senate Action on Key Economic Bill Amid Trade Reprieves and Deadline Pressure Global investment bank and financial services giant UBS published its Washington Weekly report on […]UBS spotlights blistering Senate momentum on a sweeping economic bill packed with permanent tax incentives and trade reprieves, all under crushing pressure to meet July deadlines. UBS Sees Fast-Track Senate Action on Key Economic Bill Amid Trade Reprieves and Deadline Pressure Global investment bank and financial services giant UBS published its Washington Weekly report on […]

UBS Sees Senate Rushing ‘One Big, Beautiful Bill’ Toward High-Stakes Finale

UBS spotlights blistering Senate momentum on a sweeping economic bill packed with permanent tax incentives and trade reprieves, all under crushing pressure to meet July deadlines.

UBS Sees Fast-Track Senate Action on Key Economic Bill Amid Trade Reprieves and Deadline Pressure

Global investment bank and financial services giant UBS published its Washington Weekly report on June 13, providing a comprehensive update on U.S. legislative and trade developments. The publication, issued by UBS Wealth Management USA and authored by the UBS Editorial Team, examined the progress of the “One Big, Beautiful Bill” as it moves from the House to the Senate.

The Senate Finance Committee is expected to deliver the most significant revisions, potentially softening proposed Medicaid cuts and making business tax breaks like bonus depreciation and research and development credits permanent, rather than expiring in five years as the House bill outlines. The Senate version may also narrow the state and local tax (SALT) deduction. UBS emphasized the speed of the Senate’s approach, stating:

The report detailed how Republicans are using budget reconciliation—a mechanism created by Congress in 1974 that allows certain fiscal measures to pass with a simple Senate majority—to advance the bill. While this allows the legislation to bypass the usual 60-vote threshold, it imposes strict requirements. Provisions without direct budgetary consequences, such as a 10-year federal ban on state AI regulations and energy permitting measures, may be eliminated. The Senate Parliamentarian remains the final authority on whether these provisions can be retained, and this vetting process could shape the final version of the bill.

UBS also addressed recent trade policy shifts, highlighting a temporary reprieve for the Trump administration as a federal appeals court stayed a ruling that would have overturned several tariffs imposed under emergency powers. Meanwhile, the U.S. and China reached a six-month agreement granting American access to rare earth minerals in return for limited relief on export controls. Although the broader 90-day pause on new tariff hikes—set to expire on Aug. 12—remains unresolved, the rare earths deal effectively maintains current terms.

Referring to ongoing bilateral negotiations, UBS wrote:

Treasury Secretary Bessent further indicated the administration may prolong its July 8 deadline for reaching new trade deals, even as sectoral tariffs on items like semiconductors, lumber, and pharmaceuticals remain active and legally robust.

Market Opportunity
Polytrade Logo
Polytrade Price(TRADE)
$0.04903
$0.04903$0.04903
+0.14%
USD
Polytrade (TRADE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.